Percheron Therapeutics Ltd (PER) — Cash Flow Quality Index

Latest as of June 2025: -0.84x

Percheron Therapeutics Ltd (PER) has a Cash Flow Quality Index of -0.84x as of June 2025. Operating cash flow of AU$-7.16 Million is below net income of AU$8.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Percheron Therapeutics Ltd total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.84x
Operating CF / Net Income

Operating Cash Flow

AU$-7.16 Million
AUD

Net Income

AU$8.54 Million
AUD

Data as of

Jun 2025
Most recent filing

Percheron Therapeutics Ltd Cash Flow Quality Index (2015–2015)

Historical Cash Flow Quality Index for Percheron Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Percheron Therapeutics Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Percheron Therapeutics Ltd (2015–2015)

Year-by-year earnings quality comparison for Percheron Therapeutics Ltd. For live market cap and the full company financial profile, see PER company net worth.

Year Quality Index Operating CF (AUD) Net Income YoY Change
2015 1.79x AU$1.27 Million AU$706.92K —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.